JPRN-jRCT2080220983未知3 期
Correction and Maintenance study of subcutaneous injections of R744 to predialysis patients (Phase 3, comparative study in comparison with epoetin beta).
试验速览
- 阶段
- 3 期
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Renal anemia patients before introduction of hemodialysis
排除标准
- •Female patients who are pregnant, breastfeeding, possibly pregnant
研究者
相似试验
未知
3 期
Correction and Maintenance study of subcutaneous injections of R744 to predialysis patients ( Phase III, comparative study in comparison with epoetin beta).JPRN-jRCT2080220401Chugai Pharmaceutical Co., Ltd.
未知
3 期
Switch and Maintenance study of subcutaneous or intravenous injections of R744 to Predialysis patients ( Phase III study ).Renal anemiaJPRN-jRCT2080220344Chugai Pharmaceutical Co., Ltd.
未知
3 期
Switch and Maintenance study of subcutaneous or intravenous injections of R744 to Peritoneal Dialysis patients ( Phase III study ).JPRN-jRCT2080220347Chugai Pharmaceutical Co., Ltd.
已完成
1 期
Clinical study with subsequent subcutaneous administration of GEN0101 in the patients enrolled in the Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 (GEN0101-JM003).JPRN-UMIN000026892Osaka University Hospital, Center for respiratory6
尚未招募
2 期
ESAR-814 StudyRheumatoid arthritis with moderate activityArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRPCEC00000230Center for Genetic Engineering and Biotechnology (CIGB), in Havana196